CDH1 and renal cell carcinoma: Notably, Ketorolac also caused down-regulation of VEGF at transcript and protein levels and significant upregulation of E-cadherin at the transcript levels indicative of its ability to prevent cellular migration and metastasis which is one of the major unmet need in RCC.